[#item_full_content]SAN DIEGO–(BUSINESS WIRE)–Micronoma, the first biotech company offering early cancer detection using a microbiome-driven liquid biopsy platform, today announced that Sandrine Miller-Montgomery, Ph.D., Pharm.D., CEO and Co-founder of Micronoma will participate in J.P. Morgan Week in San Francisco, CA in January 2023. Miller-Montgomery will present company updates at the following events: Event: Biotech Showcase 2023: The Investor Conference for Innovators January 9-11, 2023, San Francisco, U.S